Report Detail
Global Neurodegenerative Drugs Market Professional Survey Report 2019
- RnM3800264 |
- 03 October, 2019 |
- Global |
- 104 Pages |
- QYResearch |
- Pharma & Healthcare
Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss. Neurodegeneration is a broader term which comprises of different disease namely Parkinson’s disease, Huntington disease, Amyotrophic Lateral Sclerosis and Alzheimer’s disease. These are the most commonly occurring diseases under the condition “Neurodegeneration”.
The global Neurodegenerative Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Neurodegenerative Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neurodegenerative Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Neurodegenerative Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Neurodegenerative Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Novartis
Pfizer
Merck Serono
Biogen Idec
TEVA Pharmaceuticals
UCB
Boehringer Ingelheim
Sanofi
GlaxoSmithKline
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
NMDA
SSRIs
Dopamine Inhibitors
Segment by Application
Hospital
Research
Table of Contents
Executive Summary
1 Industry Overview of Neurodegenerative Drugs
- 1.1 Definition of Neurodegenerative Drugs
- 1.2 Neurodegenerative Drugs Segment by Type
- 1.2.1 Global Neurodegenerative Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 NMDA
- 1.2.3 SSRIs
- 1.2.4 Dopamine Inhibitors
- 1.3 Neurodegenerative Drugs Segment by Applications
- 1.3.1 Global Neurodegenerative Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Research
- 1.4 Global Neurodegenerative Drugs Overall Market
- 1.4.1 Global Neurodegenerative Drugs Revenue (2014-2025)
- 1.4.2 Global Neurodegenerative Drugs Production (2014-2025)
- 1.4.3 North America Neurodegenerative Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Neurodegenerative Drugs Status and Prospect (2014-2025)
- 1.4.5 China Neurodegenerative Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Neurodegenerative Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Neurodegenerative Drugs Status and Prospect (2014-2025)
- 1.4.8 India Neurodegenerative Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Neurodegenerative Drugs
- 2.3 Manufacturing Process Analysis of Neurodegenerative Drugs
- 2.4 Industry Chain Structure of Neurodegenerative Drugs
3 Development and Manufacturing Plants Analysis of Neurodegenerative Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Neurodegenerative Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Neurodegenerative Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Neurodegenerative Drugs Production and Capacity Analysis
- 4.2 Neurodegenerative Drugs Revenue Analysis
- 4.3 Neurodegenerative Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Neurodegenerative Drugs Regional Market Analysis
- 5.1 Neurodegenerative Drugs Production by Regions
- 5.1.1 Global Neurodegenerative Drugs Production by Regions
- 5.1.2 Global Neurodegenerative Drugs Revenue by Regions
- 5.2 Neurodegenerative Drugs Consumption by Regions
- 5.3 North America Neurodegenerative Drugs Market Analysis
- 5.3.1 North America Neurodegenerative Drugs Production
- 5.3.2 North America Neurodegenerative Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Neurodegenerative Drugs Import and Export
- 5.4 Europe Neurodegenerative Drugs Market Analysis
- 5.4.1 Europe Neurodegenerative Drugs Production
- 5.4.2 Europe Neurodegenerative Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Neurodegenerative Drugs Import and Export
- 5.5 China Neurodegenerative Drugs Market Analysis
- 5.5.1 China Neurodegenerative Drugs Production
- 5.5.2 China Neurodegenerative Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Neurodegenerative Drugs Import and Export
- 5.6 Japan Neurodegenerative Drugs Market Analysis
- 5.6.1 Japan Neurodegenerative Drugs Production
- 5.6.2 Japan Neurodegenerative Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Neurodegenerative Drugs Import and Export
- 5.7 Southeast Asia Neurodegenerative Drugs Market Analysis
- 5.7.1 Southeast Asia Neurodegenerative Drugs Production
- 5.7.2 Southeast Asia Neurodegenerative Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Neurodegenerative Drugs Import and Export
- 5.8 India Neurodegenerative Drugs Market Analysis
- 5.8.1 India Neurodegenerative Drugs Production
- 5.8.2 India Neurodegenerative Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Neurodegenerative Drugs Import and Export
6 Neurodegenerative Drugs Segment Market Analysis (by Type)
- 6.1 Global Neurodegenerative Drugs Production by Type
- 6.2 Global Neurodegenerative Drugs Revenue by Type
- 6.3 Neurodegenerative Drugs Price by Type
7 Neurodegenerative Drugs Segment Market Analysis (by Application)
- 7.1 Global Neurodegenerative Drugs Consumption by Application
- 7.2 Global Neurodegenerative Drugs Consumption Market Share by Application (2014-2019)
8 Neurodegenerative Drugs Major Manufacturers Analysis
- 8.1 Novartis
- 8.1.1 Novartis Neurodegenerative Drugs Production Sites and Area Served
- 8.1.2 Novartis Product Introduction, Application and Specification
- 8.1.3 Novartis Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Pfizer
- 8.2.1 Pfizer Neurodegenerative Drugs Production Sites and Area Served
- 8.2.2 Pfizer Product Introduction, Application and Specification
- 8.2.3 Pfizer Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Merck Serono
- 8.3.1 Merck Serono Neurodegenerative Drugs Production Sites and Area Served
- 8.3.2 Merck Serono Product Introduction, Application and Specification
- 8.3.3 Merck Serono Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Biogen Idec
- 8.4.1 Biogen Idec Neurodegenerative Drugs Production Sites and Area Served
- 8.4.2 Biogen Idec Product Introduction, Application and Specification
- 8.4.3 Biogen Idec Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 TEVA Pharmaceuticals
- 8.5.1 TEVA Pharmaceuticals Neurodegenerative Drugs Production Sites and Area Served
- 8.5.2 TEVA Pharmaceuticals Product Introduction, Application and Specification
- 8.5.3 TEVA Pharmaceuticals Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 UCB
- 8.6.1 UCB Neurodegenerative Drugs Production Sites and Area Served
- 8.6.2 UCB Product Introduction, Application and Specification
- 8.6.3 UCB Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Boehringer Ingelheim
- 8.7.1 Boehringer Ingelheim Neurodegenerative Drugs Production Sites and Area Served
- 8.7.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.7.3 Boehringer Ingelheim Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Sanofi
- 8.8.1 Sanofi Neurodegenerative Drugs Production Sites and Area Served
- 8.8.2 Sanofi Product Introduction, Application and Specification
- 8.8.3 Sanofi Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 GlaxoSmithKline
- 8.9.1 GlaxoSmithKline Neurodegenerative Drugs Production Sites and Area Served
- 8.9.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.9.3 GlaxoSmithKline Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Neurodegenerative Drugs Market
- 9.1 Global Neurodegenerative Drugs Market Trend Analysis
- 9.1.1 Global Neurodegenerative Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Neurodegenerative Drugs Regional Market Trend
- 9.2.1 North America Neurodegenerative Drugs Forecast 2019-2025
- 9.2.2 Europe Neurodegenerative Drugs Forecast 2019-2025
- 9.2.3 China Neurodegenerative Drugs Forecast 2019-2025
- 9.2.4 Japan Neurodegenerative Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Neurodegenerative Drugs Forecast 2019-2025
- 9.2.6 India Neurodegenerative Drugs Forecast 2019-2025
- 9.3 Neurodegenerative Drugs Market Trend (Product Type)
- 9.4 Neurodegenerative Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Neurodegenerative Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Neurodegenerative Drugs. Industry analysis & Market Report on Neurodegenerative Drugs is a syndicated market report, published as Global Neurodegenerative Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Neurodegenerative Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
